Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Simcere Pharmaceutical Group (NY: SCR)
9.280 USD  -0.010 (-0.11%)
Official Closing Price  /  Updated: 4:15 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 27,320
Open 9.130
Bid (Size) 8.950 (200)
Ask (Size) 11.03 (100)
Prev. Close 9.290
Today's Range 9.130 - 9.305
52wk Range 7.250 - 9.590
Shares Outstanding 50,705,211
Dividend Yield N/A
Top News
More News
More Details about Hisun-Pfizer and Merck-Simcere JVs
May 20, 2013
In 2011, the world’s two largest drugmakers – Pfizer and Merck – each announced major China drug JVs with domestic China pharmas – Hisun in Pfizer’s case and Simcere for Merck. The arrangements were... Read More
from ChinaBio® Today
UPDATE 1-Generali denies sale of U.S. business
May 13, 2013
MILAN, May 13 (Reuters) - Italy's biggest insurer Assicurazioni Generali denied reports on Monday it had sold its U.S. life reinsurance business as it presses ahead with efforts to wrap up a series of... Read More
category companyNews
from Reuters: Company News

More News
Read More
Market Chatter-Corporate finance press digest
May 10, 2013
category companyNews
from Reuters: Company News
Simcere Pharmaceutical (SCR) Improves Q1 Profit to RMB0.56/ADS
May 09, 2013
from StreetInsider.com News Articles
Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
May 09, 2013
from PR Newswire
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
May 08, 2013
from StreetInsider.com News Articles
Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
April 27, 2013
from PR Newswire
Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
April 26, 2013
from PR Newswire
Simcere Pharmaceutical Group Special Committee Retains UBS as Financial Advisor to Assist in Considering Going Private Offer
April 03, 2013
category Contracts , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
Simcere Pharmaceutical Group Announces its Special Committee's Engagement of Financial Advisor
April 03, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here